Back to Search Start Over

ECFS standards of care on CFTR-related disorders: Identification and care of the disorders.

Authors :
Simmonds, N.J.
Southern, K.W.
De Wachter, E.
De Boeck, K.
Bodewes, F.
Mainz, J.G.
Middleton, P.G.
Schwarz, C.
Vloeberghs, V.
Wilschanski, M.
Bourrat, E.
Chalmers, J.D.
Ooi, C.Y.
Debray, D.
Downey, D.G.
Eschenhagen, P.
Girodon, E.
Hickman, G.
Koitschev, A.
Nazareth, D.
Source :
Journal of Cystic Fibrosis. Jul2024, Vol. 23 Issue 4, p590-602. 13p.
Publication Year :
2024

Abstract

• CFTR-related disorders (RD) are a group of conditions caused by CFTR protein dysfunction, but to a level of dysfuncton not satisfying the diagnostic crtieria for cystic fibrosis (CF). • This paper discusses the individual disorders, including congenital absence of the vas deferens (CAVD), diffuse bronchiectasis, chronic or acute recurrent pancreatitis, allergic bronchopulmonary aspergillosis, chronic rhinosinusitis, primary sclerosing cholangitis and aquagenic wrinkling of the palms. • The CFTR functional and genetic evidence in support of each condition being a CFTR-RD are discussed and guidance for reaching the diagnosis is provided. • Gaps in our knowledge and future areas of research, including the role of CFTR modulators, are highlighted. This is the third paper in the series providing updated information and recommendations for people with cystic fibrosis transmembrane conductance regulator (CFTR)-related disorder (CFTR-RD). This paper covers the individual disorders, including the established conditions - congenital absence of the vas deferens (CAVD), diffuse bronchiectasis and chronic or acute recurrent pancreatitis - and also other conditions which might be considered a CFTR-RD, including allergic bronchopulmonary aspergillosis, chronic rhinosinusitis, primary sclerosing cholangitis and aquagenic wrinkling. The CFTR functional and genetic evidence in support of the condition being a CFTR-RD are discussed and guidance for reaching the diagnosis, including alternative conditions to consider and management recommendations, is provided. Gaps in our knowledge, particularly of the emerging conditions, and future areas of research, including the role of CFTR modulators, are highlighted. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
15691993
Volume :
23
Issue :
4
Database :
Academic Search Index
Journal :
Journal of Cystic Fibrosis
Publication Type :
Academic Journal
Accession number :
179275032
Full Text :
https://doi.org/10.1016/j.jcf.2024.03.008